Vaccine War: India Vs West| World's first Nasal Vaccine for Covid-19 iNCOVACC

India Today
25 Jan 202308:09

Summary

TLDRThe video script reflects on India's resilience during the COVID-19 pandemic, emphasizing its self-reliance in producing vaccines like Covishield and Covaxin. Despite skepticism from the Western media, India emerged as a leader in global vaccine diplomacy, providing vaccines to other nations through its Vaccine Maitri initiative. The video contrasts India’s affordable vaccine distribution with the profit-driven practices of Western pharmaceutical giants like Pfizer. It highlights India’s historic vaccine achievements, including the launch of the world’s first intranasal COVID-19 vaccine, showcasing India’s capability as a global healthcare leader.

Takeaways

  • 💉 India's resilience during the COVID-19 pandemic was highlighted by its ability to produce vaccines just in time, saving its people without waiting for foreign help.
  • 🌍 By 2023, India became a global leader in vaccine diplomacy, having administered over 220 crore doses of COVID-19 vaccines.
  • 🇮🇳 India's main vaccines during the pandemic were Covishield (AstraZeneca) and Covaxin (Bharat Biotech), with these vaccines helping to prevent a resurgence of the virus despite new variants like BF.0.7.
  • 📦 India overcame logistical challenges to deliver vaccines to even remote areas, showcasing a well-coordinated effort across its vast population and terrain.
  • 🌐 Through the Vaccine Maitri initiative, India supplied vaccines to developing nations, positioning itself as a world leader in humanitarian aid and vaccine manufacturing.
  • 🏭 Indian pharmaceutical companies produce more than 50% of the global demand for vaccines, with a manufacturing capacity of 8.2 billion doses annually.
  • 💵 Unlike the US, where drug prices are high due to limited government regulation, India has price controls on essential drugs, making them more affordable and accessible.
  • ⚠️ Pfizer faced criticism for imposing indemnity clauses on smaller nations during the pandemic, while India's vaccines were more accessible and didn't come with such conditions.
  • 🔬 India relied on traditional vaccine methods using inactivated viruses, unlike mRNA vaccines, which have raised concerns about long-term effects.
  • 👃 India is set to launch the world's first intranasal COVID-19 vaccine, which promises to be cost-effective, scalable, and suitable for mass immunization in low- and middle-income countries.

Q & A

  • How did India's response to the COVID-19 pandemic demonstrate its resilience?

    -India demonstrated its resilience by effectively managing the crisis through a timely vaccination drive, overcoming logistical challenges, and public hesitancy, without waiting for external aid to save its population.

  • What are the two main COVID-19 vaccines used in India?

    -The two main COVID-19 vaccines used in India are Covishield, which is the Oxford-AstraZeneca vaccine manufactured in India, and Covaxin, developed by the Indian firm Bharat Biotech.

  • How has India's vaccination drive impacted public health?

    -The vaccination drive in India has significantly reduced the number of severe COVID-19 cases, helping the country manage the pandemic more effectively.

Outlines

plate

Cette section est réservée aux utilisateurs payants. Améliorez votre compte pour accéder à cette section.

Améliorer maintenant

Mindmap

plate

Cette section est réservée aux utilisateurs payants. Améliorez votre compte pour accéder à cette section.

Améliorer maintenant

Keywords

plate

Cette section est réservée aux utilisateurs payants. Améliorez votre compte pour accéder à cette section.

Améliorer maintenant

Highlights

plate

Cette section est réservée aux utilisateurs payants. Améliorez votre compte pour accéder à cette section.

Améliorer maintenant

Transcripts

plate

Cette section est réservée aux utilisateurs payants. Améliorez votre compte pour accéder à cette section.

Améliorer maintenant
Rate This

5.0 / 5 (0 votes)

Étiquettes Connexes
COVID-19India resilienceVaccine diplomacyPharma industryGlobal healthPandemic responseVaccine innovationMade in IndiaWestern mediaVaccine leadership
Besoin d'un résumé en anglais ?